Search Within

Susan E Prockop

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (11)
Groups
  1. Center for Hematologic Malignancies (25)
  2. Department of Medicine (25)
  3. GSK Faculty (25)
  4. Human Oncology and Pathogenesis Program (25)
  5. Pediatrics, Department of (25)
  6. Sloan Kettering Institute Faculty (25)

More Groups

People
  1. Richard O'Reilly (23)
  2. James Young (22)
  3. Nancy Kernan (22)
  4. Marcel Van Den Brink (21)
  5. Miguel-Angel Perales (21)
  6. Farid Boulad (20)

More People

Years
  1. 2022 (2)
  2. 2020 (2)
  3. 2017 (1)
  4. 2016 (1)
  5. 2015 (3)
  6. 2014 (1)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (13)
  2. Blood (9)
  3. Blood Advances (1)
  4. Bone Marrow Transplantation (1)
  5. Journal of Clinical Investigation (1)
Publishers
  1. Elsevier Inc. (13)
  2. American Society of Hematology (10)
  3. American Society for Clinical Investigation (1)
  4. Nature Publishing Group (1)

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy
    Journal Article

    Hasan, A. N.; Doubrovina, E.; Sottile, R.; Prockop, S.; Klatt, M. G.; Heller, G.; Selvakumar, A.; Barnett, L.; Hsu, K. C.; O’Reilly, R. J.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant
    Journal Article

    Miltiadous, O.; Waters, N. R.; Andrlová, H.; Dai, A.; Nguyen, C. L.; Burgos da Silva, M.; Lindner, S.; Slingerland, J.; Giardina, P.; Clurman, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • A chemotherapy-only regimen of busulfan, melphalan, and fludarabine, and rabbit antithymocyte globulin followed by allogeneic T-cell depleted hematopoietic stem cell transplantations for the treatment of myeloid malignancies
    Journal Article

    Spitzer, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Fuller, K.; Hilden, P. D.; Young, J. W.; Barker, J. N.; Koehne, G.; Perales, M. A.; Hsu, K. C.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling for improved diagnosis and therapy of pediatric acute leukemias
    Meeting Abstract

    Kobos, R.; He, J.; Steinherz, P. G.; Curran, K. J.; Renaud, T. M.; Forlenza, C.; Boulad, F.; Prockop, S.; Knapp, K. M.; Walsh, M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Barker, J.; Castro-Malaspina, H.; Curran, K.; Giralt, S.; Hasan, A.; Heller, G.; Hsu, K.; Jakubowski, A.; more...
    Bone Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Intensified mycophenolate mofetil dosing and higher mycophenolic acid trough levels reduce severe acute graft-versus-host disease after double-unit cord blood transplantation
    Journal Article

    Harnicar, S.; Ponce, D. M.; Hilden, P.; Zheng, J.; Devlin, S. M.; Lubin, M.; Pozotrigo, M.; Mathew, S.; Adel, N.; Kernan, N. A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation
    Journal Article

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S. M.; Lubin, M.; Giralt, S.; Goldberg, J. D.; Hanash, A.; Hsu, K.; Jenq, R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M.; Evans, K.; Prockop, S. E.; Scaradavou, A.; Kernan, N.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save